Improving Adherence Among HIV+ Rwandan Youth: A TI-CBTe Indigenous Leader Model
Human Immunodeficiency Virus
About this trial
This is an interventional treatment trial for Human Immunodeficiency Virus
Eligibility Criteria
Inclusion Criteria:
- male or female
- 14-21 years old
- seeking HIV care and treatment
- enrolled in support groups at CHUK or We-ACTx For Hope
- able to understand the informed consent process.
Exclusion Criteria:
- are unable to understand the consent/assent process
- do not speak Kinyarwanda (all instruments will be translated and back-translated)
- are not HIV+
- received an HIV diagnosis in the past week
Sites / Locations
- Cental University Hospital of Kigali - CHUK
- WE-ACTx for Hope
Arms of the Study
Arm 1
Arm 2
No Intervention
Active Comparator
Control
Treatment
Usual care: WE-ACTx For Hope and CHUK offer a host of services for HIV+ young people, and these will represent the "usual care" condition for the study. Both clinics provide adolescent-friendly environments with multidisciplinary teams that offer weekly or monthly support groups, peer education, medical services, mental health screenings, sports activities, HIV and health education sessions, and outreach to parents and guardians. The services youth in the "usual care" condition receive will be carefully tracked.
Culturally-adapted, trauma-informed cognitive behavioral therapy (TI-CBT) intervention: The components of the TI-CBT include a) psychosocial health education b) relaxation training c) cognitive restructuring d) adherence barriers e) caregiver psycho-education. The TI-CBTe will be administered in groups of 8-10 weekly for 2 hours for 3 Sundays each month over 2 months. Two IYL will co-lead each intervention, and two IYL will rate fidelity.